Circulating markers of liver function and cardiovascular disease risk

by Targher, Giovanni, Byrne, Christopher D.
Published 2015

Letter. Targeting C-reactive protein for the treatment of cardiovascular disease

by Pepys, M.B, Hirschfield, G.M, Tennent, G.A, Gallimore, J.R, Kahan, M.C, Bellotti, V., Hawkins, P.N, Myers, R.M, Smith, M.D, Polara, A., Cobb, A.J.A, Vey, S.V, Aquilina, J.A, Robinson, C.V, Sharif, I., Gray, G.A, Sabin, C.A, Jenvey, M.C, Kolstoe, S.E, Thompson, D., Wood, S.P
Published 2006

Modifiable cardiovascular disease risk factors among indigenous populations

by Lucero, Adam A., Lambrick, Danielle M., Faulkner, James A., Fryer, Simon, Tarrant, Michael A., Poudevigne, Melanie, Williams, Michelle A., Stoner, Lee
Published 2014

A conceptual framework for managing modifiable risk factors for cardiovascular diseases in Fiji

by Witter, T., Poudevigne, M., Lambrick, D.M, Faulkner, J., Lucero, A.A, Page, R., Perry, L.G, Tarrant, M.A, Stoner, L.
Published 2015

The relationship between depression, anxiety and cardiovascular disease: findings from the Hertfordshire Cohort Study

by Holt, R.I.G, Phillips, D.I.W, Jameson, K.A, Cooper, C., Dennison, E.M, Peveler, R.C
Published 2013

Patient factors influencing the prescribing of lipid lowering drugs for primary prevention of cardiovascular disease in UK general practice: a national retrospective cohort study

by Wu, J., Zhu, S., Yao, Guiqing Lily, Mohammed, M.A, Marshall, T.
Published 2013

Transcriptional profiling of rats subjected to gestational undernourishment: implications for the developmental variations in metabolic traits

by Morris, Tiffany J., Vickers, Mark, Gluckman, Peter, Gilmour, Stewart, Affara, Nabeel
Published 2009

Passive smoking assessed by salivary cotinine and self-report in relation to cause-specific mortality: 17-year follow-up of study participants in the UK Health and Lifestyle Survey

by Batty, G.D, Gale, C.R, Jefferies, B., Kvaavik, E.
Published 2014

The metabolic syndrome: common origins of a multifactorial disorder

by Bruce, K.D, Byrne, C.D
Published 2009

Non alcoholic fatty liver disease (NAFLD): new challenge for general practitioners and important burden for health authorities?

by Ahmed, Mohamed H., Abu, Emmanuel O., Byrne, Christopher D.
Published 2010

UVA irradiation of human skin vasodilates arterial vasculature and lowers blood pressure independently of nitric oxide synthase

by Liu, Donald, Fernandez, Bernadette O., Hamilton, Alistair, Lang, Ninian N., Gallagher, Julie M.C, Newby, David E., Feelisch, Martin, Weller, Richard B
Published 2014

Premenopausal advantages in postprandial lipid metabolism are lost in women with type 2 diabetes

by Masding, Michael G., Stears, Anna J., Burdge, Graham C., Wootton, Stephen A., Sandeman, Derek D.
Published 2003

Early life origins of all-cause and cause-specific disability pension: findings from the Helsinki birth cohort study

by von Bondorff, M.B, Tomakangas, T., Salonen, M., von Bonsdorff, M.E, Osmond, C., Kajantie, E., Eriksson, J.G
Published 2015

Fatty liver: role of inflammation and fatty acid nutrition

by Byrne, Christopher D.
Published 2010

Ezetimibe as a potential treatment for non alcoholic fatty liver disease: is the intestine a modulator of hepatic insulin sensitivity and hepatic fat accumulation?

by Ahmed, Mohamed H., Byrne, Christopher D.
Published 2010

Potential therapeutic uses for ezetimibe beyond lowering LDL-c to decrease cardiovascular events

by Ahmed, M.H, Byrne, Christopher D.
Published 2010

Current treatment of non-alcoholic fatty liver disease

by Ahmed, Mohamed H., Byrne, Christopher D.
Published 2008

Clinical and laboratory diagnosis of the metabolic syndrome

by Olufadi, R., Byrne, C.D
Published 2008

Temple syndrome as a result of isolated hypomethylation of the 14q32 imprinted DLK1/MEG3 region

by Briggs, Tracy A., Lokulo-Sodipe, Kemi, Chandler, Kate E., Mackay, Deborah J.G, Temple, I. Karen
Published 2016

FLAP inhibitors for the treatment of inflammatory diseases

by Sampson, A.P
Published 2009